Helix Biopharma Corp.
HBP.TO
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.72M | -6.89M | -7.15M | -6.85M | -6.79M |
| Total Depreciation and Amortization | 7.10K | 8.60K | 9.40K | 10.20K | 10.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.10K | 2.51M | 2.48M | 2.42M | 2.59M |
| Change in Net Operating Assets | 963.60K | 1.56M | 1.99M | 1.30M | 348.30K |
| Cash from Operations | -2.74M | -2.81M | -2.67M | -3.11M | -3.85M |
| Capital Expenditure | -1.40K | -2.90K | -2.90K | -1.50K | -10.30K |
| Sale of Property, Plant, and Equipment | 13.60K | 13.60K | 13.60K | 5.90K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 12.20K | 10.70K | 10.70K | 4.40K | -10.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.80M | 3.90M | 5.52M | 2.82M | 5.51M |
| Repurchase of Common Stock | -1.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.97M | 2.77M | 3.97M | 2.07M | 4.05M |
| Foreign Exchange rate Adjustments | -- | 18.30K | 12.40K | -8.30K | -200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -755.00K | -11.00K | 1.33M | -1.05M | 192.50K |